| ||||||
| Meeting of the American Academy of Ophthalmology 2008 Highlights from the 2008 congress of the American Academy of Ophthalmology (AAO), held 8–11 November in Atlanta, Georgia, US. Please click on any of the headlines below to see the full story. Lowering risk of 25 G surgery TVT study: 3-year results announced Distinct DME patterns seen on OCT Phaco benefits on IOP even better Post LASIK cataract surgery woes AAO news in briefWavefront better for night driving Laser refractive surgery conducted with wavefront-guided procedures are associated with better night driving outcomes when compared with traditional LASIK treatments. Femtosecond similarities A study of two femtosecond lasers (IntraLase FS60; AMO & Ziemer LDV; Ziemer) found that both lasers produced very similar results at all time points examined after LASIK. A new postLASIK entity? Surgeons should consider the diagnosis of LASIK chronic pain syndrome in post LASIK patients complaining of moderate to severe eye pain in the absence of dry eye or any other identifiable cause. Boosting glaucoma adherence The Latanoprost Punctal Plug Drug Delivery System, a drug-eluting implantable stent/ punctal plug device, reduced IOP by a mean of approximately 30% in trial subjects and may increase patient compliance. Retention rates were, however, low. DME treatment safe A Phase I dose-escalation trial of rapamycin (Sirolimus, Wyeth) showed that the drug is safe and has biologic activity against diabetic macular oedema (DME). Avastin for CME Twelve month study results have shown that intravitreal bevacizumab (Avastin; Genentech) is a promising treatment of refractory pseudophakic cystoid macular oedema (CME). OT awards writer Jonathan Etter, MD, of the Duke Eye Center, Duke University, Durham, North Carolina, US won first-place honours in the sixth annual Ophthalmology Times Resident Writer's Award programme, for his presentation "Fungal keratitis: enhancing antifungal delivery with femtosecond laser-assisted keratectomy." Ptosis could indicate serious illness Ptosis, a symptom of many benign disorders, is also associated with myasthenia gravis, which first presents with ocular symptoms in over 90% of cases. Doctors should not overlook this potentially serious condition (and its high rate of morbidity and mortality) when treating ptosis. Diet aid for retinopathy DiaVis (ScienceBased Health) — a nutritional supplement, which delivers antioxidants as an aid to boost the vision of diabetics — has been launched. Secondary piggyback IOLs Given the right conditions, a secondary piggyback IOL may be the most successful solution for post-phaco refractive issues. A low-profile 3-piece IOL is the best option for this. Dry eye in LASIK patients Treating dry eye prior to, and taking steps to prevent its development following, LASIK surgery is the best way to minimize the incidence of this condition. Low-contrast acuity is a reliable screening tool, and patients whose preop dry eye does not interfere with vision are good candidates for surgery. Maculopathy: laser still best Despite growing support for anti-VEGF drug therapies, the Early Treatment Diabetic Retinopathy Study (ETDRS) laser remains the gold standard of care for diabetic maculopathy. Anti-VEGFs for DME? Anti-VEGFs may be a viable adjunctive treatment to vitrectomy or laser therapy for diabetic macular oedema (DME), having proved effective in trials as a temporary treatment of diabetic retinopathy.
For up-to-date news and announcements, please check the latest news section of our website. Alternatively, please sign up for our weekly newsletter. |
| |||||||||||||||||||||||||||||||||||